Patients with Staphylococcus aureus colonization of an intravascular catheter but without demonstrated bacteremia within 24 h after intravascular catheter removal had a 24% (12 of 49 patients) chance of subsequent S. aureus bacteremia if they did not receive immediate antistaphylococcal antibiotics. Treatment within 24 h after intravascular catheter removal led to a 83% reduction in the incidence of subsequent bacteremia.
Patients with Staphylococcus aureus colonization of an intravascular catheter but without demonstrated bacteremia within 24 h after intravascular catheter removal had a 24% (12 of 49 patients) chance of subsequent S. aureus bacteremia if they did not receive immediate antistaphylococcal antibiotics. Treatment within 24 h after intravascular catheter removal led to a 83% reduction in the incidence of subsequent bacteremia.
Whether "patients with positive results of quantitative or semiquantitative catheter cultures (but with negative blood culture results) and no other obvious site of infection need to be treated with antibiotics" [1, p. 1267 ] was defined as an area for future research in the Infectious Diseases Society of America guidelines for management of intravascular (IV) catheter-related infections. IV catheter tip colonization with Staphylococcus aureus is strongly associated with concomitant bacteremia [2, 3] , and therefore, an IV catheter tip culture yielding S. aureus is generally regarded as an alarming signal. However, evidence guiding the appropriate medical care in such circumstances is lacking. Several studies have evaluated the consequences of infected or colonized IV catheters in patients with concomitant bacteremia. To our knowledge, the outcomes of patients who had IV catheter colonization with S. aureus but who did not have concomitant bacteremia have been assessed only once [4] .
Because there was no protocol for guiding treatment of patients with IV catheter tip cultures positive for S. aureus in the absence of concomitant bacteremia, practices differed widely among treating physicians; furthermore, blood cultures were not consistently performed for all patients. Therefore, we retrospectively assessed the incidence of bacteremic complications in patients with S. aureus-colonized catheter tips who did not have concomitant bacteremia, as well as the effects of antibiotic therapy.
Patients and methods. Patients with S. aureus cultured from intravascular catheters during the period 1 June 2001-1 October 2006 were identified in the database of the bacteriology department of the University Medical Center Utrecht (a tertiary care hospital with 1024 beds in Utrecht, The Netherlands). From the same database, it was determined whether blood cultures had been performed for these patients in the 24 h before and after IV catheter removal and whether the patients had had any blood culture positive for S. aureus during the 6 months before and after catheter removal. Patients with blood cultures positive for S. aureus during the period from 48 h before through 24 h after IV catheter removal were excluded from the analysis. Risk factors were recorded from the patient charts, and all patients were observed for a 6-month period beginning the day of IV catheter removal.
A subsequent bacteremic complication was defined as S. aureus bacteremia (SAB) 124 h after removal of the IV catheter, with an isolate with a susceptibility pattern identical to that of the catheter tip. Treatment of S. aureus infection was defined as any therapy (intravenous or oral) for which the cultured S. aureus strain was susceptible; treatment was started within 24 h after removal of the IV catheter and continued for a minimum of 3 days. An IV catheter exit site infection was defined as redness, swelling, purulence, or tenderness of the IV catheter exit site.
Catheter tips were processed as described elsewhere [5] . A culture result was considered to be positive when the culture yielded у15 colony forming units. Blood cultures were incubated for a minimum of 5 days at 35ЊC.
Risk factors for subsequent S. aureus bacteremic complications were analyzed using Fisher's exact test and the x 2 test for nominal variables, and the Mann-Whitney U test was used for continuous variables. Statistically significant risk factors were subsequently analyzed by multivariate logistic regression. Furthermore, the association between antibiotic treatment, which was putatively the main protective factor, and signs and symptoms of infection were determined [6] .
Results. During the 63-month period, 184 patients had intravascular catheter tips that were positive for S. aureus, 99 3 or with 110% immature forms, heart rate 190 beats per min, and respiratory rate 1 20 breaths per min). a Documented symptoms of IV catheter exit site infection in patients without subsequent SAB were dysfunctioning ( ), redness ( ), purulence n p 3 n p 25 ( ), and pain ( ; some symptoms overlapped); documented symptoms of IV catheter exit site infection in patients with SAB were redness ( ), n p 23 n p 9 n p 4 purulence ( ), and pain ( ); some symptoms overlapped. n p 6 n p 2 b Includes S. aureus-positive specimens (determined by culture) obtained from a site other than the IV catheter or the IV catheter exit site within 24 h after IV catheter removal. In patients without subsequent SAB, S. aureus-positive specimens were from the respiratory tract ( ), CAPD fluid ( ), abdominal n p 11 n p 1 wound drainage ( ), and wound infection ( ); in patients with subsequent SAB, 1 patient had a positive sputum culture result. n p 1 n p 1 (54%) of whom had no evidence of SAB up to 24 h after catheter removal. 
Fourteen patients experienced subsequent SAB for a mean duration of 6.7 days after removal of the IV catheter (median duration of SAB after catheter removal, 3 days; range, 2-25 days). Risk factors for SAB and characteristics of the patients are displayed in table 1. Twelve (24%) of 49 patients who did not receive antibiotic treatment developed subsequent SAB, which contributed directly to death in 2 patients (4%). The first patient who died was a 67-year-old woman who underwent resection of a hepatocellular carcinoma; she died of fulminant S. aureus sepsis, which manifested 3 days after removal of the IV catheter. The second patient who died was a 57-year-old woman who had been admitted to the hospital for abdominal surgery; she was discharged from the hospital the same day that her IV catheter was removed, but 2 days later, she was readmitted to the hospital with S. aureus sepsis, of which she died. Furthermore, in a third patient who experienced terminal heart failure, it is likely that S. aureus bacteremia aggravated the underlying disease, ultimately leading to death. Two (4%) of the 50 treated patients had subsequent complications; 1 of these patients had thrombophlebitis, and 1 had IV catheterassociated SAB. Other complications are shown in table 2. Thus, antibiotic treatment had a protective effect for subsequent SAB (OR, 0.13; 95% CI, 0.02-0.61); this result was significant in Table 2 ). Six-month survival was 84.0% in the P p .13 patients who received antibiotic treatment and 79.6% in patients who did not receive antibiotic treatment (
). An-P p .32 tibiotic treatment was associated with the presence of systemic inflammatory response syndrome [6] (table 3) but not with documented signs of exit site infection.
Discussion. Colonization of IV catheters with S. aureus was associated with a 14% incidence of subsequent bacteremic complications, and these complications occurred more frequently in patients who did not receive antistaphylococcal antibiotics within 24 h after catheter removal than in patients who received antibiotics during the same period (24% vs. 4%). Thus, antibiotic treatment was associated with an 83% lower risk of subsequent SAB. In a previous study, 39% of patients with S. aureus isolated from catheter tips who did not have concomitant bacteremia developed SAB within 12 weeks, and antibiotic therapy was associated with a 91% reduction in the incidence of subsequent SAB [4] . The results of these 2 studies strongly suggest that antibiotic treatment of all patients with S. aureus-positive IV catheter tips could prevent a considerable number of bacteremic complications.
We considered antibiotic treatment to be immediate when it was initiated within 24 h after IV catheter removal. In other studies evaluating outcomes of SAB, a period of 48 h after documentation of bacteremia or tip colonization has been used [4, 7] . However, IV catheter tip colonization with S. aureus can be demonstrated within 24 h after catheter removal in most well-equipped bacteriological laboratories; therefore, a 48-h period does not reflect standard care [8] . Our conclusions, however, would not change if we had considered antibiotic treatment initiated within 48 h after catheter removal to be immediate treatment.
The association between catheter tip colonization and subsequent SAB (as well as the observed protective effects of antibiotics) may have been underestimated in our study. The decision of physicians to initiate antibiotic treatment was not protocolized. Prescription of antibiotics was strongly associated with the presence of signs and symptoms of (systemic) infection; therefore, patients at highest risk for subsequent SAB had probably already received treatment more frequently, introducing a bias against the observed correlation.
Because of its retrospective design, this study has several limitations. Blood cultures were not performed in a protocolized manner, and S. aureus strains were not available for typing. Because the decision to culture catheter tips was probably made on the basis of clinical findings, it is likely that a selected subset of IV catheter tips was cultured; therefore, the results may not be extrapolated to a scenario in which all catheter tips are cultured. Finally, the number of patients included was small, compared with the number of risk factors evaluated, compromising the power of both the univariate and the multivariate analyses.
In addition to lack of antibiotic therapy, only corticosteroid use was significantly associated with subsequent SAB. For other potential risk factors, such as total parenteral nutrition, type of IV catheter, and the duration of catheter presence before removal, only trends toward an association with subsequent SAB could be demonstrated. Larger prospective studies are needed to identify risk factors for subsequent SAB and to establish the optimal duration of treatment; for the moment, however, in the absence of randomized prospective trials, the best available evidence supports rapid antibiotic treatment of all patients with S. aureus-positive IV catheter tips.
